CompletedNot applicableNCT02809170

The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases

Studying Mitochondrial disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tawam Hospital
Principal Investigator
Ayman W El-Hattab, MD
Tawam Hospital
Intervention
Arginine(dietary_supplement)
Enrollment
9 target
Eligibility
3-18 years · All sexes
Timeline
20162019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02809170 on ClinicalTrials.gov

Other trials for Mitochondrial disease

Additional recruiting or active studies for the same condition.

See all trials for Mitochondrial disease

← Back to all trials